SunLink Health Systems Q4 EPS $(0.33) Down From $0.64 YoY, Sales $9.88M Down From $10.34M YoY

SunLink Health Systems (AMEX:SSY) reported quarterly losses of $(0.33) per share. This is a 151.56 percent decrease over earnings of $0.64 per share from the same period last year. The company reported $9.88 million in

SunLink Health Systems (AMEX:SSY) reported quarterly losses of $(0.33) per share. This is a 151.56 percent decrease over earnings of $0.64 per share from the same period last year. The company reported $9.88 million in sales this quarter. This is a 4.39 percent decrease over sales of $10.34 million the same period last year.

Total
0
Shares
Related Posts
Read More

IGM Announces Pricing Of $107.3M Upsized Public Offering Of 3,285,327 Shares Of Its Voting Common Stock And 7,312,500 Shares Of Its Non-Voting Common Stock At $8/Share; Also Concurrent Private Placement Of 2,812,500 At $8/Share

IGM Biosciences, Inc. (NASDAQ:IGMS) today announced the pricing of its upsized underwritten public offering of 3,285,327 shares of its voting common stock and 7,312,500 shares of its non-voting common stock, in each case

IGMS

Read More

Mirati Therapeutics And Aadi Bioscience Partner To Evaluate The Combination Of Adagrasib With Nab-sirolimus In Patients With Advanced Non-Small Cell Lung Cancer And Other Solid Tumors With A KRAS[G12C] Mutation

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company, and Aadi Bioscience, Inc. (NASDAQ:AADI), a commercial stage biopharmaceutical company focused on developing and commercializing

AADI